Antitrust Antitrust

Geistlich Pharma's Chinese subsidiary hit with fine by market regulator for RPM (English version)

By MLex Staff
  • 15 Apr 2022 00:17
  • 15 Apr 2022 00:17
Below is an English translation of the penalty decision, provided by MLex. The original decision in Chinese can be found here.

Geistlich subsidiary fined by Chinese regulator for RPM

Investigative procedure

Geistlich Trading (Beijing) (hereinafter referred to as “Geistlich Trading”), a subsidiary of Geistlich Pharma, was placed under investigation in November 2020 by the Beijing

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

TAKE A FREE TRIAL

Latest News